Miltenyi Biotec

Miltenyi Biotec, founded in 1989 and headquartered in Bergisch Gladbach, Germany, is a privately-held global leader in providing enabling technologies for the life sciences, particularly in the rapidly growing fields of cell and gene therapy. The company operates on a platform and services business model, generating revenue from the sale of its proprietary instruments, reagents, and contract development and manufacturing services. Its integrated solutions, built around technologies like MACS® and CliniMACS®, are industry standards for cell separation and processing, positioning it as a critical infrastructure provider for both research and clinical applications.

Proprietary integrated platforms for cell and gene therapy, including MACS® (Magnetic-Activated Cell Sorting) technology for cell separation, the CliniMACS® platform for GMP-compliant clinical cell processing, and associated instruments, reagents, and software for research, development, and manufacturing.

Miltenyi Biotec competes with large, diversified life science tools companies like Thermo Fisher Scientific and BD Biosciences in research tools, and with specialized firms like Sartorius, Lonza, and Cytiva in bioprocessing and cell therapy manufacturing. Its deep focus on magnetic cell separation and integrated CGT solutions provides a strong niche position.